4//SEC Filing
Eleven Biotherapeutics, Inc. 4
Accession 0001485003-16-000050
$CARMCIK 0001485003operating
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:11 PM ET
Size
7.5 KB
Accession
0001485003-16-000050
Insider Transaction Report
Form 4
Celniker Abbie
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-02-25+113,250→ 113,250 totalExercise: $0.28Exp: 2026-02-24→ Common Stock (113,250 underlying) - Award
Stock Option (Right to Buy)
2016-02-25+90,000→ 90,000 totalExercise: $0.28Exp: 2026-02-24→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]This option was granted February 25, 2016 and vests over four years in equal quarterly installments, with the first installment vesting on March 31, 2016.
- [F2]This option was granted on February 25, 2016 and vests over two years in equal monthly installments, with the first installment vesting on March 25, 2016.
Documents
Issuer
Eleven Biotherapeutics, Inc.
CIK 0001485003
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001485003
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 5:11 PM ET
- Size
- 7.5 KB